Funder: CMT Research Foundation
Due Dates: Quarterly (invited full proposals; specific deadlines and current submission availability unconfirmed)
Funding Amounts: Typically $100,000–$200,000 per year for one to three years; higher budgets considered
Summary: Supports research leading to therapeutics for all types of Charcot-Marie-Tooth disease, with the goal of delivering treatments and cures.
Key Information: A Letter of Intent and invitation are required before submitting a full proposal.
Description
The CMT Research Foundation (CMTRF), a patient-led nonprofit, funds promising research that advances therapeutics for all types of Charcot-Marie-Tooth disease (CMT). Its primary focus is translational research, while discovery-stage projects are supported when they have a clear link to accelerating treatments and cures. The foundation prioritizes projects with the highest likelihood of leading to clinical trials and approved treatments in the near term.
Funding decisions follow CMTRF’s research priorities: advancing gene therapy, promoting nerve health, overcoming drug-delivery challenges, and de-risking clinical trials. Researchers with other promising ideas or approaches are encouraged to contact the foundation. Projects use defined aims and milestones appropriate to their stage and scope, with Scientific Advisory Board review and opportunities for advice from CMT and industry advisors.
